A decreased albumin level has been interpreted as a possible consequence of tumor progression and a biomarker of cachexia (Goodrose-Flores et al. 2022, Stares et al. 2021, Lipshitz et al. 2024), rather than low albumin having any direct causative effects on prognosis. This evidence concerns the gene ALB and neoplasm.